39. Deputy Eoin Ó Broin asked the Minister for Health if he or his Department has had consultation with the European Medicines Agency, EMA, on the application for market authorisation in the EU for the drug nusinersen; the timeframe, following a decision from the EMA, in which the National Centre for Pharmacoeconomics, NCPE, can commence its own process for assessment; the timeframe for this drug to be available; and if he will make a statement on the matter. [4554/17]

Summary

39. Deputy Eoin Ó Broin asked the Minister for Health if he or his Department has had consultation with the European Medicines Agency, EMA, on the application for market authorisation in the EU for the drug nusinersen; the timeframe, following a decision from the EMA, in which the National Centre for Pharmacoeconomics, NCPE, can commence its own process for assessment; the timeframe for this drug to be available; and if he will make a statement on the matter. [4554/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 1 February 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.